U.S. COPD Market - Therapeutic Overview and Patient Outlook

Abstract

This research service covers the U.S. COPD market from 2003-2013. Included are patient forecasts and a therapeutic overview. The market is segmented by product class: bronchodilators, anti-inflammatories, combination therapies, and novel therapeutic approaches. The novel therapeutic approaches segment covers selected products in the pipeline that are outside current marketed segments. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.